Sun Pharmaceutical Industries has received an approval from US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for generic version of Zyprexa Zydis, Olanzapine ODT, 5 mg, 10 mg, 15 mg and 20 mg.
These generic Olanzapine orally disintegrating tablets, 5 mg, 10 mg, 15 mg and 20 mg are therapeutic equivalents of Eli Lilly’s Zyprexa Zydis tablets. Olanzapine orally disintegrating tablets have annual sale of approximately $360 million in the US.
Olanzapine OD tablets are indicated for the treatment of schizophrenia, bipolar I disorder (manic or mixed episodes).
Sun Pharmaceutical Industries manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.
